Tag Archives: Drug

GAO Dings FDA’s Orphan Drug Program

The FDA has failed to ensure that drugs given prized rare-disease status meet the intent of a 35-year-old law, federal officials revealed in a report Friday. The Government Accountability Office (GAO), which spent more than a year investigating the FDA’s orphan drug program, said “challenges continue” in the program that was created to spur development… Read More »